AML/CFTR 4.4.3 Measures in addition to enhanced CDD and ongoing monitoring

In addition to the enhanced CDD and enhanced ongoing monitoring in this Part, a firm must conduct, on a risk-sensitive basis:

(a) countermeasures proportionate to the risks specified in circulars published by the NAMLTF Committee based on relevant findings of international organisations, governments and other bodies; and
(b) other measures determined by the NAMLTF Committee on its own initiative.
Derived by QFCRA RM/2019-8 (as from 1st February 2020)